Literature DB >> 21995321

Quantitative distribution of mRNAs encoding the 19 human UDP-glucuronosyltransferase enzymes in 26 adult and 3 fetal tissues.

Michael H Court1, Xiuling Zhang, Xinxin Ding, Karen K Yee, Leah M Hesse, Moshe Finel.   

Abstract

The purpose of this study was to generate, by real-time PCR, a quantitative expression level profile of the 19 human UDP-glucuronosyltransferases (UGTs) of subfamilies 1A, 2A and 2B, in 26 adult and 3 fetal tissues, for better understanding of their roles in xenobiotic and endobiotic metabolism. Adult liver contained the highest level of combined UGTs mRNA, and UGT2B4 was the most abundant isoform in this tissue (40% of total). Other well expressed hepatic UGTs, in decreasing order of mRNA level, were 1A9, 2B7, 1A4, 2B10, 1A1, 1A6, 2B11, 2B15, 1A3, 2A3, 2B17 and 2B28. UGT2B4 was by far the most abundant isoform in the fetal liver (90% of total). The combined UGT mRNA expression in both adult and fetal olfactory epithelium was high, about 20% the adult hepatic level. Interestingly, a large developmental change was found in this tissue from high UGT2A1 and UGT2A2 expression in the fetus to UGT1A6 in the adult. The most abundantly expressed UGTs in the small intestine were 2A3, 1A10, 1A1, 1A6 and 2B7, while 1A10 and 2A3 predominated in the colon. The results provide the most comprehensive data to date on the tissue distribution of the human UGTs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21995321     DOI: 10.3109/00498254.2011.618954

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  52 in total

1.  Glucuronidation of OTS167 in Humans Is Catalyzed by UDP-Glucuronosyltransferases UGT1A1, UGT1A3, UGT1A8, and UGT1A10.

Authors:  Jacqueline Ramírez; Snezana Mirkov; Larry K House; Mark J Ratain
Journal:  Drug Metab Dispos       Date:  2015-04-13       Impact factor: 3.922

2.  Polymorphic Expression of UGT1A9 is Associated with Variable Acetaminophen Glucuronidation in Neonates: A Population Pharmacokinetic and Pharmacogenetic Study.

Authors:  Matthew W Linakis; Sarah F Cook; Shaun S Kumar; Xiaoxi Liu; Diana G Wilkins; Roger Gaedigk; Andrea Gaedigk; Catherine M T Sherwin; John N van den Anker
Journal:  Clin Pharmacokinet       Date:  2018-10       Impact factor: 6.447

3.  Multiplexed Targeted Quantitative Proteomics Predicts Hepatic Glucuronidation Potential.

Authors:  Guillaume Margaillan; Michèle Rouleau; Kathrin Klein; John K Fallon; Patrick Caron; Lyne Villeneuve; Philip C Smith; Ulrich M Zanger; Chantal Guillemette
Journal:  Drug Metab Dispos       Date:  2015-06-15       Impact factor: 3.922

4.  Mechanistic Assessment of Extrahepatic Contributions to Glucuronidation of Integrase Strand Transfer Inhibitors.

Authors:  Stephanie N Liu; Jessica Bo Li Lu; Christy J W Watson; Philip Lazarus; Zeruesenay Desta; Brandon T Gufford
Journal:  Drug Metab Dispos       Date:  2019-02-25       Impact factor: 3.922

5.  Quantitative profiling of the UGT transcriptome in human drug-metabolizing tissues.

Authors:  A Tourancheau; M Rouleau; S Guauque-Olarte; L Villeneuve; I Gilbert; A Droit; C Guillemette
Journal:  Pharmacogenomics J       Date:  2017-04-25       Impact factor: 3.550

6.  UGT2B gene expression analysis in multiple tobacco carcinogen-targeted tissues.

Authors:  Nathan R Jones; Philip Lazarus
Journal:  Drug Metab Dispos       Date:  2014-01-23       Impact factor: 3.922

7.  Cellular asymmetric catalysis by UDP-glucuronosyltransferase 1A8 shows functional localization to the basolateral plasma membrane.

Authors:  Kerstin Ziegler; Sarka Tumova; Asimina Kerimi; Gary Williamson
Journal:  J Biol Chem       Date:  2015-01-13       Impact factor: 5.157

8.  Comparative metabolism of mycophenolic acid by glucuronic acid and glucose conjugation in human, dog, and cat liver microsomes.

Authors:  J E Slovak; K Mealey; M H Court
Journal:  J Vet Pharmacol Ther       Date:  2016-06-15       Impact factor: 1.786

Review 9.  Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part I: In Vitro Systems and Physiological Data.

Authors:  Daniel Scotcher; Christopher Jones; Maria Posada; Amin Rostami-Hodjegan; Aleksandra Galetin
Journal:  AAPS J       Date:  2016-06-30       Impact factor: 4.009

10.  Identification of Uridine 5'-Diphosphate-Glucuronosyltransferases Responsible for the Glucuronidation of Mirabegron, a Potent and Selective β3-Adrenoceptor Agonist, in Human Liver Microsomes.

Authors:  Kentaro Konishi; Daisuke Tenmizu; Shin Takusagawa
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-06       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.